Procedural complication and long term outcomes after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: data from China

被引:14
|
作者
An, Shuo-yan [1 ,2 ]
Yang, Yin-jian [1 ,2 ]
Hang, Fei [1 ,2 ]
Wang, Zhi-min [2 ,3 ]
Fan, Chao-mei [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Key Lab Clin Trial Res Cardiovasc Drugs, Minist Hlth, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Ultrasound, Beijing, Peoples R China
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
关键词
TASK-FORCE; FOLLOW-UP; MYECTOMY; SURVIVAL; METAANALYSIS; GUIDELINE; DIAGNOSIS; DEATH; YOUNG;
D O I
10.1038/s41598-017-10144-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data on procedural complications and long term survival after alcohol septal ablation (ASA) in Chinese patients with obstructive hypertrophic cardiomyopathy (HOCM) are lacking. We aimed to investigate long-term survival of HOCM patients after ASA and compared to the non-obstructive hypertrophic cardiomyopathy(NOHCM). A total of 233 patients with HOCM and a peak pressure gradient of >= 50 mm Hg at rest or with provocation were consecutively enrolled from Fuwai Hospital in China between 2000 and 2012. Another 297 patients without left ventricular outflow tract obstruction were regarded as control group. Periprocedural mortality of ASA were low (0.89%). Periprocedural lethal ventricular arrhythmia occurred in 9 patients (4.0%). Alcohol volume (RR 1.44, 95% CI: 1.03-2.03, P = 0.034) and age <= 40 years old (RR 4.63, 95% CI: 1.07-20.0, P = 0.040) were independent predictors for periprocedural lethal ventricular arrhythmia. The 10-year overall survival was 94.6% in the ASA group, similar with 92.9% in the NOHCM group (P = 0.930). In conclusion, periprocedural mortality and complications were rare in ASA. Long term survival after ASA were satisfactory and comparable to NOHCM. Patients under 40 years old should be more cautious undergoing ASA, for these patients were more likely to endure lethal ventricular arrhythmia during periprocedural period of ASA.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Procedural complication and long term outcomes after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: data from China
    Shuo-yan An
    Yin-jian Yang
    Fei Hang
    Zhi-min Wang
    Chao-mei Fan
    Scientific Reports, 7
  • [2] Sex and outcomes after alcohol septal ablation for patients with hypertrophic obstructive cardiomyopathy
    Nagueh, Sherif F.
    HEART, 2022, 108 (20) : 1588 - 1589
  • [3] Favorable Long-Term Outcomes After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy in Japan
    Tokita, Yukichi
    Matsuda, Junya
    Imori, Yoichi
    CIRCULATION JOURNAL, 2024, 88 (01) : 133 - 134
  • [4] Long-term outcomes after medical therapy, alcohol septal ablation, and myectomy in patients with hypertrophic obstructive cardiomyopathy
    Zhai, S. S.
    Yang, Y. J.
    Fan, C. M.
    Qiao, S. B.
    Wang, S. Y.
    Song, Y. H.
    Yuan, J. S.
    You, S. J.
    Guo, X. Y.
    An, S. Y.
    Wang, Z. M.
    Duan, F. J.
    Li, Y. S.
    EUROPEAN HEART JOURNAL, 2016, 37 : 232 - 232
  • [5] Procedural Complications and Outcomes in Patients With Hypertrophic Obstructive Cardiomyopathy Undergoing Septal Myomectomy Versus Alcohol Septal Ablation
    Udongwo, Ndausung
    Mararenko, Anton
    Imburgio, Steven
    Johal, Anmol
    Pannu, Viraaj
    Dandu, Sowmya
    Akhlaq, Hira
    Eltawansy, Sherif
    Adeniyi, Adeyinka
    Weze, Kelechi
    Heaton, Joseph
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (17) : B213 - B213
  • [6] The Impact of Race and Gender on Procedural Outcomes After Alcohol Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy
    Benton, Stewart M.
    Rier, Jeremy D.
    Panuccio, Alexandria
    Shaji, Shawn
    Griffin, Barbara E.
    Neathawk, John M.
    Litwin, Sheldon E.
    Nielsen, Christopher D.
    Fernandes, Valerian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B305 - B306
  • [7] Outcomes of Patients With Hypertrophic Obstructive Cardiomyopathy and Pacemaker Implanted After Alcohol Septal Ablation
    Veselka, Josef
    Liebregts, Max
    Cooper, Robert
    Faber, Lothar
    Januska, Jaroslav
    Kashtanov, Maksim
    Tesarkova, Klara Hulikova
    Hansen, Peter Riis
    Seggewiss, Hubert
    Shloydo, Eugene
    Popov, Kirill
    Hansvenclova, Eva
    Bonaventura, Jiri
    ten Berg, Jurrien
    Stables, Rodney Hilton
    Polakova, Eva
    JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (19) : 1910 - 1917
  • [8] Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy
    Liebregts, Max
    Faber, Lothar
    Jensen, Morten K.
    Vriesendorp, Pieter A.
    Januska, Jaroslav
    Krejci, Jan
    Hansen, Peter R.
    Seggewiss, Hubert
    Horstkotte, Dieter
    Adlova, Radka
    Bundgaard, Henning
    ten Berg, Jurrien M.
    Veselka, Josef
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (11) : 1135 - 1143
  • [9] Effect of Alcohol Dosage on Long-Term Outcomes After Alcohol Septal Ablation in Patients With Hypertrophic Cardiomyopathy
    Liebregts, Max
    Vriesendorp, Pieter A.
    Steggerda, Robbert C.
    Schinkel, Arend F. L.
    Balt, Jippe C.
    Ten Cate, Folkert J.
    Michels, Michelle
    Ten Berg, Jurrien M.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 88 (06) : 945 - 952
  • [10] Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy
    Batzner, Angelika
    Pfeiffer, Barbara
    Neugebauer, Anna
    Aicha, Diaa
    Blank, Christoph
    Seggewiss, Hubert
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (24) : 3087 - 3094